Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clarus (CLAR) Cash & Equivalents (2016 - 2025)

Clarus (CLAR) has disclosed Cash & Equivalents for 16 consecutive years, with $29.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents changed N/A year-over-year to $29.5 million, compared with a TTM value of $29.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $45.4 million, up 300.56% over the prior year.
  • Cash & Equivalents was $29.5 million for Q3 2025 at Clarus, up from $28.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $46.2 million in Q2 2024 and bottomed at $6.8 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $22.1 million, with a median of $16.5 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents plummeted 68.51% in 2021, then skyrocketed 300.56% in 2024.
  • Year by year, Cash & Equivalents stood at $19.5 million in 2021, then tumbled by 38.45% to $12.0 million in 2022, then decreased by 5.48% to $11.3 million in 2023, then surged by 300.56% to $45.4 million in 2024, then crashed by 34.95% to $29.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for CLAR at $29.5 million in Q3 2025, $28.5 million in Q2 2025, and $41.3 million in Q1 2025.